Lorraine Jordan
About Lorraine Jordan
Lorraine Jordan is the Director of Quality Control at Kite Pharma, with over 18 years of experience in the pharmaceutical and biotechnology industry. She has held various roles in analytical development and quality control across multiple companies in the Netherlands.
Current Role at Kite Pharma
Lorraine Jordan currently serves as the Director of Quality Control (TCF04) at Kite Pharma, a position she has held since 2020. She works in Hoofddorp, North Holland, Netherlands. In this role, she oversees quality control processes and ensures compliance with industry standards. Her leadership is crucial in maintaining the integrity of Kite Pharma's products.
Previous Experience at Kite Pharma
Before her current role, Lorraine Jordan worked at Kite Pharma as the Associate Director of Quality Control Analytical from 2018 to 2020 in Amsterdam. During this time, she contributed to the analytical quality control processes, enhancing the company's operational efficiency and product quality.
Career Background in the Pharmaceutical Industry
Lorraine Jordan has over 18 years of experience in the pharmaceutical and biotechnology industry. She has progressed through various roles, starting as an Analytical Technician and advancing to Director of Quality Control. Her career includes significant positions at companies such as uniQure, OctoPlus, and Janssen Pharmaceutical Companies of Johnson & Johnson.
Education and Expertise in Bioanalytical Science
Lorraine Jordan earned a Master of Science (M.Sc.) in Bioanalytical Science from the Institute of Technology, Tallaght, where she studied from 1997 to 2004. This educational background has equipped her with a strong foundation in analytical development and quality control, essential for her roles in the pharmaceutical sector.
Work History at OctoPlus
At OctoPlus, Lorraine Jordan held multiple positions, including Project Manager from 2007 to 2010, Quality Control Manager from 2010 to 2014, and Scientist from 2005 to 2007. Her diverse roles at OctoPlus allowed her to develop a comprehensive understanding of quality control and analytical processes within the pharmaceutical industry.